Roche oral Cytovene gains CMV prevention indication in AIDS patients.
Executive Summary
ROCHE ORAL CYTOVENE GAINS CMV PREVENTION INDICATION for AIDS-related cytomegalovirus infection Oct. 27 via FDA approval of a supplemental NDA. "Cytovene capsules are indicated for the prevention of CMV disease in individuals with advanced HIV infection at risk for developing CMV disease," labeling states.